Login / Signup

Repeat transurethral resection is still an essential tool in treating non-muscle invasive bladder cancer: the Western Australian experience.

Dwayne T S ChangAlarick Picardo
Published in: Bladder (San Francisco, Calif.) (2020)
Repeat TUR should remain an essential practice due to high rates of residual disease and a small risk of tumor under-staging. The presence of detrusor muscle and macroscopic clearance should not be used as surrogates for adequacy of resection or consideration of avoiding a repeat TUR, even for TaHG disease.
Keyphrases
  • muscle invasive bladder cancer
  • primary care
  • skeletal muscle
  • lymph node
  • south africa
  • pet ct
  • quality improvement
  • botulinum toxin